Perrigo Company plc is an American Irish registered manufacturer of private label over-the-counter pharmaceuticals.
| Revenue (TTM) | $4.18B |
| Gross Profit (TTM) | $1.43B |
| EBITDA | $637.30M |
| Operating Margin | 3.47% |
| Return on Equity | -52.20% |
| Return on Assets | 2.09% |
| Revenue/Share (TTM) | $30.11 |
| Book Value | $18.09 |
| Price-to-Book | 0.61 |
| Price-to-Sales (TTM) | 0.36 |
| EV/Revenue | 1.148 |
| EV/EBITDA | 8.41 |
| Quarterly Earnings Growth (YoY) | -63.60% |
| Quarterly Revenue Growth (YoY) | -7.20% |
| Shares Outstanding | $138.37M |
| Float | $137.62M |
| % Insiders | 0.39% |
| % Institutions | 116.53% |
Volatility is currently expanding